MAVS and autoimmune disease: However, when second signals are scarce and weak, such as in the early stages of an autoimmune disease, MAVS deficiency could significantly impact B cell activation and renders “protection” to disease development, as observed in MAVS and FcγR2b double deficient mice (21).